Introduction
Helicobacter pylori, or H. pylori, facilitates the occurrence of peptic ulcer diseases and also functions as a risk factor for gastric cancer. The eradication of this organism can lead to ulcer healing and the minimization of risks associated with ulcer complications and recurrences. As such, an initial management plan for a patient with peptic ulcer disease must focus on testing and treatment (Cleveland Clinic, 2020). This is especially important as individuals with non-ulcer dyspepsia may not even be affected by testing or treatment. Patients with undifferentiated dyspepsia will likely benefit from a primary test-and-treat tactic.
Discussion
The most common factors that contribute to treatment failure are antimicrobial resistance and an incomplete treatment regimen. As such, an initial management plan must introduce a multidrug intervention and an appropriate length of treatment in order to eradicate the microorganism completely. Like most lengthy treatment and management plans, a healthcare professional should consider the convenience and tolerability of their provided interventions for the patient. The most reliable management plans have been cited to be at least fourteen days in length in the case of peptic ulcer diseases (Narayanan et al., 2018). The primary focus of the initial management plan would be on accommodating the patient to multidrug pharmacological therapy. This includes the use of antibiotics, acid reducers, and bismuth compounds. Similarly important in the beginning stages of treatment is the education of the patient on their condition and the specifics of the utilized interventions.
Conclusion
This is likely to contribute to the success of the management plan as patients will be informed on the necessary avoidance of factors contributing to the worsening of the peptic ulcer disease. Additionally, there may be benefits to considering a follow-up management plan in case the first exposure to treatment is not successful in reducing or eradicating the organism.
References
Cleveland Clinic. (2020). Peptic ulcer disease. Cleveland Clinic. Web.
Narayanan, M., Reddy, K. M., & Marsicano, E. (2018). Peptic ulcer disease and Helicobacter pylori infection. The Journal of the Missouri State Medical Association, 115(3), 219–224. Web.